The growing trend of securing private industry funding for biomedical research, particularly from pharmaceutical and medical device companies, has raised significant ethical concerns. Since the 1980s, private industry has become the primary funder of biomedical research, surpassing government funding in the U.S. and other developed countries. This ...

By Jovan Kulić, Dragana Aksentijević, Ana Kostović, Dejan Krstić, Dragana Branović, Bojan Joksimović, Marija Milić, Stefan Mitić, Siniša Ristić